跳至主要内容
临床试验/NCT07830550
NCT07830550Enrolling By Invitation不适用

ALPCO Syphilis-T (Treponema Pallidum) CLIA Kit and ALPCO Syphilis-NT (Non-Treponemal Lipoidal Antigen) CLIA Kit Blood Donation Protocol

American Laboratory Products Company1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2026年10月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
Enrolling By Invitation
发起方
入组人数
50
试验地点
1
主要终点
Number of Blood Specimens Successfully Processed Into Serum

研究概览

简要总结

This prospective, single-center study will collect blood from approximately 50 adult volunteers aged 22 years or older. Participants will provide informed consent, complete an eligibility review, and undergo one blood draw of approximately 20-50 mL.

The blood will be processed into serum and labeled with a study identification number. The serum may be used to prepare laboratory samples with defined antibody levels to support the development and performance evaluation of the ALPCO Syphilis-T and Syphilis-NT assays. All testing is for research purposes only. Individual test results will not be provided to participants or used for diagnosis or treatment.

详细描述

Syphilis is a sexually transmitted infection caused by the bacterium Treponema pallidum. Laboratory diagnosis commonly includes treponemal tests, which detect antibodies specific to T. pallidum, and non-treponemal tests, which detect antibodies associated with cellular damage and may help assess disease activity.

Serum collected under this study will serve as a human serum matrix for preparing contrived specimens. These specimens may be created by adding characterized reactive serum or other appropriately characterized materials to produce predefined levels of treponemal or non-treponemal reactivity. Before use, the serum may be evaluated using appropriate reference or comparator methods to confirm its suitability.

The resulting specimens will support analytical and, when scientifically and regulatorily appropriate, clinical performance evaluations of the ALPCO Syphilis-T and Syphilis-NT assays. The specific preparation procedures, target reactivity levels, testing methods, and acceptance criteria will be defined in the applicable performance-study protocols.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Prospective

入排标准

年龄范围
22 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Male or female adults aged 22 years or older Able and willing to provide written informed consent Able and willing to provide a blood sample in accordance with the protocol

排除标准

  • Unable or unwilling to provide written informed consent Unable or unwilling to undergo venipuncture Any medical condition that would make blood collection unsafe, as determined by study personnel

研究组 & 干预措施

Adult Volunteer Blood Donors

Adult volunteers aged 22 years or older who provide one blood sample for serum collection and research use.

干预措施: ALPCO Syphilis-T (Device)

Adult Volunteer Blood Donors

Adult volunteers aged 22 years or older who provide one blood sample for serum collection and research use.

干预措施: ALPCO Syphilis-NT CLIA Kits (Device)

结局指标

主要结局

Number of Blood Specimens Successfully Processed Into Serum

时间窗: Day 1, following the single study visit and serum processing

The number of enrolled participants from whom approximately 20-50 mL of whole blood is successfully collected and processed into serum suitable for research use in the development and performance evaluation of the ALPCO Syphilis-T and Syphilis-NT assays.

次要结局

未报告次要终点

研究者

发起方
American Laboratory Products Company
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验